Filtered Listing Testing
Learn about a promising new technology for monitoring the progression of glaucoma, why age is a risk factor for glaucoma, a new approach for regenerating an injured optic nerve, the importance of clinical trials, and more in the spring edition of the National Glaucoma Research Report.
Laine Hardy, American Idol Winner 2019, will make his charitable debut at BrightFocus Foundation’s awards gala. Richard Lui, MSNBC, will emcee the research and advocacy awards for diseases of mind and sight.
BrightFocus Foundation is hosting its fourth annual dinner to celebrate and showcase some of the world’s most promising science to end Alzheimer’s disease, macular degeneration and glaucoma.
At ARVO 2019, the world’s largest gathering of vision scientists, BrightFocus grantees stood out for their insights into key cells in the retina and surrounding tissue that participate in macular degeneration.
Learn what LATE is, the brain regions that are affected by this disorder, how many people may have this form of dementia, how it is currently diagnosed, and the next steps for research.
BrightFocus Foundation, a premier source of private research funding to defeat Alzheimer’s disease, macular degeneration, and glaucoma, today announced $16.2 million for 76 new research grants, a record high for the organization. With these latest grant awards, BrightFocus will have invested $43 million in scientific research over the past three years alone.
The spring edition of the Alzheimer's Disease Research Review provides articles on dementia and depression, a potential new blood test to screen for Alzheimer’s, a research project to identify early midlife biomarkers for Alzheimer’s disease risk with regard to sex-based differences in brain aging and memory decline, Alzheimer's disease in women, and more.
BrightFocus Foundation joins others in mourning the loss of the legendary Paul Greengard, PhD, who passed away this past week on April 13. He was both an early grantee and longtime friend of BrightFocus, and became our honorary board member in 2010.
An update on the macular degeneration drug pipeline, the signs and symptoms of age-related macular degeneration (AMD), a new clinical trial that aims to reduce the frequency of wet AMD injections, the role of sleep apnea in AMD, and more are found in the spring 2019 edition of Macular Degeneration Research News.